Sthanu Subramanian/X
Apr 5, 2026, 16:16
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Sthanu Subramanian, Pediatrician, shared a post on X:
”Antiphospholipid Syndrome (APS), also known as Hughes’ Syndrome, an autoimmune condition where the body produces abnormal antibodies (such as Lupus antibody, Anti-cardiolipin, and Anti-β2-glycoprotein 1) that attack cell membrane components.
This process increases the risk of dangerous blood clots in both arteries and veins.”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 16:36Piotr Czempik: Patient Blood Management Means Safer Care, Better Quality, and Responsible Resource Use
-
Apr 12, 2026, 16:31Eishi Asano: Available Evidence and Unmet Needs in EEG Use During Stroke Management
-
Apr 12, 2026, 16:23Jack Shuang Hou: CorTec Wins 1st-Ever FDA Breakthrough Device Designation for BCI in Stroke Motor Rehabilitation
-
Apr 12, 2026, 15:54Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
-
Apr 12, 2026, 15:38Hugo Antonio Romo Rubio: ASH ISTH 2026 Guidelines on Prophylactic Anticoagulation In Pediatrics
-
Apr 12, 2026, 15:26Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
-
Apr 12, 2026, 14:58Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition